Form 4: Soligenix Director Acquires Stock Options

Robert J. Rubin, a director at Soligenix, Inc., acquired 8,646 stock options on December 12, 2024.

Summary

• Robert J. Rubin, a director of Soligenix, Inc., was granted 8,646 stock options on December 12, 2024.
• The exercise price of these options is $3.47 per share.
• The options vest ratably on March 12, 2025, June 12, 2025, September 12, 2025, and December 12, 2025.
• The options expire on December 11, 2034.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of a stock option grant, which is neither positive nor negative in itself. It is a neutral event.

Positives

• The acquisition of stock options by a director could indicate confidence in the company's future performance.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's securities. It is a routine disclosure and does not indicate any specific industry trend.

Comparison to Industry Standards

• Stock option grants to directors are a common practice in publicly traded companies as part of their compensation packages.
• The vesting schedule of the options is typical, with vesting occurring over a period of time to incentivize long-term performance.
• The exercise price is set at a specific value, which is standard for stock options.

Stakeholder Impact

• The stock option grant could be seen positively by shareholders as it aligns the director's interests with the company's long-term success.

Key Dates

Keywords

Stock Options, Director, Soligenix, SNGX, Robert J. Rubin, Equity, Beneficial Ownership